LOTEMAX (Bausch & Lomb Incorporated)
Welcome to the PulseAid listing for the LOTEMAX drug offered from Bausch & Lomb Incorporated. This Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Bausch & Lomb Incorporated |
| NON-PROPRIETARY NAME: | loteprednol etabonate |
| SUBSTANCE NAME: | LOTEPREDNOL ETABONATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| ROUTE: | OPHTHALMIC |
| DOSAGE FORM: | GEL |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2012-10-12 |
| END MARKETING DATE: | 0000-00-00 |
LOTEMAX HUMAN PRESCRIPTION DRUG Details:
| Item Description | LOTEMAX from Bausch & Lomb Incorporated |
| LABELER NAME: | Bausch & Lomb Incorporated |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/g) |
| START MARKETING DATE: | 2012-10-12 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 24208-503_ab64187e-7927-497b-ab4d-a0380cf9bca3 |
| PRODUCT NDC: | 24208-503 |
| APPLICATION NUMBER: | NDA202872 |
Other LOTEPREDNOL ETABONATE Pharmaceutical Manufacturers / Labelers:
